Article Text
Abstract
Botulinum toxin (BoNT) injections are an effective treatment for cervical dystonia. Approximately 20% of patients eventually stop BoNT treatment, mostly because of treatment failure. These recommendations review the different therapeutic interventions for optimising the treatment in secondary poor responder patients. Immunoresistance has become less common over the years, but the diagnosis has to be addressed with a frontalis test or an Extensor Digitorum Brevis test. In case of immunoresistance to BoNT-A, we discuss the place the different therapeutic options (BoNT-A holidays, BoNT-B injections, alternative BoNT-A injections, deep brain stimulation). When poor responders are not immunoresistant, they benefit from reviewing (1) injections technique with electromyography or ultrasound guidance, (2) muscles selection and (3) dose of BoNT. In addition, in both scenarios, a holistic approach including drug treatment, retraining and psychological support is valuable in the management of these complex and severe cervical dystonia.
- BOTULINUM TOXIN
- cervical dystonia
- poor responders to treatment
- British Neurotoxin Network
- BNN guidelines
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Linked Articles
- Editors' commentary
Other content recommended for you
- A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia
- Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases
- Symptomatic and functional outcome of surgical treatment of cervical dystonia
- Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia
- Selective peripheral denervation for cervical dystonia: long-term follow-up
- Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study
- Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study
- Interhemispheric difference of pallidal local field potential activity in cervical dystonia
- Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®